Saturday 17 October 2026
Export ICCT’s income statement to Excel — free account
iCoreConnect Inc.
ICCT Healthcare Health Information Services
iCoreConnect Inc.’s revenue for fiscal 2024 (year ended December 2024) was $10.7 million, up 31.8% from fiscal 2023. In the quarter to December 2024, revenue fell 12.4%, EPS grew 92.5% and free cash flow grew 91.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
0.00
0.00
NaN
Follow ICCT
| Older periods | Mar '24 | Jun '24 | Sep '24 | Dec '24 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.34 | 0.86 | 0.35 | 0.17 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(12.24) | (478.62) | (15.24) | (0.92) | |
P/B ratio |
1.96 | 21.59 | 0.00 | 0.00 | |
Price to Tangible BV |
2.58 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.46 | 1.16 | 0.64 | 0.33 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.52) | (1.50) | (0.85) | (1.11) | |
EV/FCF |
(1.36) | (1.36) | (0.74) | (1.24) | |
Quick Ratio |
0.05 | 0.07 | 0.08 | 0.08 | |
Current Ratio |
0.11 | 0.11 | 0.11 | 0.10 | |
Net Debt/EBITDA |
(0.46) | (0.45) | (2.33) | (0.85) | |
Debt/Assets |
5.82% | 18.68% | 24.34% | 34.76% | |
Debt/Equity |
0.19 | 7.93 | (1.15) | (0.20) | |
Asset Turnover |
0.17 | 0.20 | 0.72 | 1.01 | |
Operating CF/Net income |
0.19 | 0.00 | 0.04 | 0.20 | |
Capex/Depreciation |
(0.46) | (0.17) | (0.70) | 2.00 | |
Interest Coverage |
(13.43) | (14.93) | (9.86) | (5.82) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
165.97% | 297.52% | 120.33% | 171.96% | |
Intangible Assets out of Total Assets |
0.07 | 0.09 | 0.10 | 0.26 | |
Share Based Compensation of Revenue |
18.64% | 170.92% | 25.29% | 29.98% | |
Graham Net Nets |
(1.07) | (1.76) | (4.14) | (7.89) | |
Graham Number |
0.00 | 0.00 | 88.78 | 117.98 | |
Earnings Yield |
(200.19%) | (358.47%) | (902.86%) | (1,832.21%) | |
Free Cash Flow Yield |
(79.72%) | (98.58%) | (251.06%) | (159.96%) | |
Revenue per Share |
5.39 | 6.01 | 5.12 | 2.96 | |
Operating CF per Share |
(1.96) | (0.04) | (0.46) | (2.72) | |
Capex per Share |
(0.66) | (0.26) | (1.04) | 1.88 | |
Free Cash Flow per Share |
(2.62) | (0.29) | (1.50) | (0.84) | |
Cash per Share |
0.27 | 0.48 | 0.39 | 0.28 | |
Shareholders Equity per Share |
12.23 | 0.80 | (5.54) | (13.51) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.23 | 0.80 | (5.54) | (13.51) | |
Free Cash Flow |
(1.32) | (0.15) | (0.82) | (0.61) | |
Working Capital |
(10.91) | (11.50) | (11.67) | (11.25) | |
Capital Expenditures |
(0.33) | (0.13) | (0.57) | 1.36 | |
Net Current Asset Value |
(12.99) | (15.58) | (15.79) | (14.30) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.12 | 0.04 | 0.20 | (0.63) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.43 | 0.53 | 0.70 | 0.69 | |
Average Payables |
2.85 | 3.47 | 5.02 | 4.01 | |
Average Assets |
52.57 | 51.66 | 15.31 | 10.69 | |
Average Common Equity |
2.80 | (0.85) | 1.69 | (2.68) |
Columns are period end dates